"Risk Assessment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
| Descriptor ID |
D018570
|
| MeSH Number(s) |
E05.318.740.600.800.715 N04.452.871.715 N05.715.360.750.625.700.690 N06.850.505.715 N06.850.520.830.600.800.715
|
| Concept/Terms |
Risk Assessment- Risk Assessment
- Assessments, Risk
- Risk Assessments
- Health Risk Assessment
- Assessment, Health Risk
- Assessments, Health Risk
- Health Risk Assessments
- Risk Assessment, Health
- Risk Assessments, Health
- Assessment, Risk
Benefit-Risk Assessment- Benefit-Risk Assessment
- Assessment, Benefit-Risk
- Assessments, Benefit-Risk
- Benefit Risk Assessment
- Benefit-Risk Assessments
- Risk-Benefit Assessment
- Assessment, Risk-Benefit
- Assessments, Risk-Benefit
- Risk Benefit Assessment
- Risk-Benefit Assessments
|
Below are MeSH descriptors whose meaning is more general than "Risk Assessment".
Below are MeSH descriptors whose meaning is more specific than "Risk Assessment".
This graph shows the total number of publications written about "Risk Assessment" by people in this website by year, and whether "Risk Assessment" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 5 | 6 |
| 1997 | 2 | 5 | 7 |
| 1998 | 0 | 4 | 4 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 12 | 12 |
| 2001 | 2 | 22 | 24 |
| 2002 | 0 | 34 | 34 |
| 2003 | 2 | 50 | 52 |
| 2004 | 4 | 57 | 61 |
| 2005 | 2 | 58 | 60 |
| 2006 | 7 | 41 | 48 |
| 2007 | 9 | 64 | 73 |
| 2008 | 2 | 83 | 85 |
| 2009 | 6 | 84 | 90 |
| 2010 | 6 | 98 | 104 |
| 2011 | 2 | 147 | 149 |
| 2012 | 6 | 121 | 127 |
| 2013 | 6 | 118 | 124 |
| 2014 | 19 | 122 | 141 |
| 2015 | 20 | 109 | 129 |
| 2016 | 15 | 144 | 159 |
| 2017 | 21 | 156 | 177 |
| 2018 | 19 | 155 | 174 |
| 2019 | 31 | 156 | 187 |
| 2020 | 22 | 155 | 177 |
| 2021 | 16 | 113 | 129 |
| 2022 | 0 | 44 | 44 |
| 2023 | 0 | 57 | 57 |
| 2024 | 1 | 124 | 125 |
| 2025 | 0 | 123 | 123 |
| 2026 | 0 | 32 | 32 |
To return to the timeline,
click here.
Below are the most recent publications written about "Risk Assessment" by people in Profiles.
-
Association of Polygenic Risk Scores With Aortic Valve Calcium: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2026 May 19; 15(10):e040064.
-
A smoking-related plasma protein score and smoking-related cancer risk and mortality in the Atherosclerosis Risk in Communities study. J Natl Cancer Inst. 2026 May 01; 118(5):917-925.
-
Brain-Derived Neurotrophic Factor in Acute Coronary Syndromes: Beyond Diagnosis Toward Biological Phenotyping and Risk Stratification. Int J Mol Sci. 2026 Apr 25; 27(9).
-
AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review. Gastroenterology. 2026 Jun; 170(7):1606-1615.
-
Derivation and Validation of Risk Prediction Models for Cardiovascular and Kidney Outcomes of Non-ST-Segment-Elevation Acute Coronary Syndrome in Patients With Chronic Kidney Disease. J Am Heart Assoc. 2026 Apr 21; 15(8):e045139.
-
Development and Internal Validation of a Pretransplant Biomarker Panel for Mortality Prediction Following Liver Transplant. JAMA Surg. 2026 Apr 01; 161(4):339-350.
-
Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort. J Natl Cancer Inst. 2026 Apr 01; 118(4):746-750.
-
Higher Sessile Serrated Lesion Detection Rates Calculated Using All Examinations Are Associated With Lower Risk for Postcolonoscopy Colorectal Cancer: Data From the New Hampshire Colonoscopy Registry. Clin Transl Gastroenterol. 2026 Apr 01; 17(4):e00987.
-
Development of a neurologic deterioration risk score in pediatric mild traumatic brain injury and intracranial injuries. J Trauma Acute Care Surg. 2026 05 01; 100(5):795-803.
-
Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy. Med. 2026 May 08; 7(5):101076.